Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$763,433
+$108,090 QoQ
Shares Held
3,006
+12.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#3,279
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pines Wealth Management, LLC holds $12,160,051 across 7 Drug Manufacturers - General names. JNJ ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,765 | $5,715,284 | |
| 2 | ABBV |
AbbVie Inc.
|
7,808 | $1,964,805 | |
| 3 | AMGN |
Amgen Inc
|
5,035 | $1,823,274 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,388 | $1,206,358 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
3,006 | $763,433 | |
| 6 | AZN |
Astrazeneca PLC
|
2,176 | $412,613 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,171 | $274,284 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $763,433 | 3,006 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $655,343 | 2,681 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $567,043 | 2,740 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $485,985 | 2,621 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $384,930 | 2,520 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $494,534 | 2,982 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $485,200 | 3,355 | Shares | Sole | 2025-01-14 | |
| No filing history on record for this holder in this stock. | ||||||